Maternal risk factors for the VACTERL association: A EUROCAT case-control study.


Journal

Birth defects research
ISSN: 2472-1727
Titre abrégé: Birth Defects Res
Pays: United States
ID NLM: 101701004

Informations de publication

Date de publication:
15 05 2020
Historique:
received: 06 03 2020
revised: 28 03 2020
accepted: 07 04 2020
pubmed: 23 4 2020
medline: 19 8 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

The VACTERL association (VACTERL) is the nonrandom occurrence of at least three of these congenital anomalies: vertebral, anal, cardiac, tracheoesophageal, renal, and limb anomalies. Despite suggestions for involvement of several genes and nongenetic risk factors from small studies, the etiology of VACTERL remains largely unknown. To identify maternal risk factors for VACTERL in offspring in a large European study. A case-control study was performed using data from 28 EUROCAT registries over the period 1997-2015 with case and control ascertainment through hospital records, birth and death certificates, questionnaires, and/or postmortem examinations. Cases were diagnosed with VACTERL, while controls had a genetic syndrome and/or chromosomal abnormality. Data collected included type of birth defect and maternal characteristics, such as age, use of assisted reproductive techniques (ART), and chronic illnesses. Multivariable logistic regression analyses were performed to estimate confounder adjusted odds ratios (aOR) with 95% confidence intervals (95% CI). The study population consisted of 329 VACTERL cases and 49,724 controls with recognized syndromes or chromosomal abnormality. For couples who conceived through ART, we found an increased risk of VACTERL (aOR 2.3 [95% CI 1.3, 3.9]) in offspring. Pregestational diabetes (aOR 3.1 [95% CI 1.1, 8.6]) and chronic lower obstructive pulmonary diseases (aOR 3.9 [95% CI 2.2, 6.7]) also increased the risk of having a child with VACTERL. Twin pregnancies were not associated with VACTERL (aOR 0.6 [95% CI 0.3, 1.4]). We identified several maternal risk factors for VACTERL in offspring befitting a multifactorial etiology.

Sections du résumé

BACKGROUND
The VACTERL association (VACTERL) is the nonrandom occurrence of at least three of these congenital anomalies: vertebral, anal, cardiac, tracheoesophageal, renal, and limb anomalies. Despite suggestions for involvement of several genes and nongenetic risk factors from small studies, the etiology of VACTERL remains largely unknown.
OBJECTIVE
To identify maternal risk factors for VACTERL in offspring in a large European study.
METHODS
A case-control study was performed using data from 28 EUROCAT registries over the period 1997-2015 with case and control ascertainment through hospital records, birth and death certificates, questionnaires, and/or postmortem examinations. Cases were diagnosed with VACTERL, while controls had a genetic syndrome and/or chromosomal abnormality. Data collected included type of birth defect and maternal characteristics, such as age, use of assisted reproductive techniques (ART), and chronic illnesses. Multivariable logistic regression analyses were performed to estimate confounder adjusted odds ratios (aOR) with 95% confidence intervals (95% CI).
RESULTS
The study population consisted of 329 VACTERL cases and 49,724 controls with recognized syndromes or chromosomal abnormality. For couples who conceived through ART, we found an increased risk of VACTERL (aOR 2.3 [95% CI 1.3, 3.9]) in offspring. Pregestational diabetes (aOR 3.1 [95% CI 1.1, 8.6]) and chronic lower obstructive pulmonary diseases (aOR 3.9 [95% CI 2.2, 6.7]) also increased the risk of having a child with VACTERL. Twin pregnancies were not associated with VACTERL (aOR 0.6 [95% CI 0.3, 1.4]).
CONCLUSION
We identified several maternal risk factors for VACTERL in offspring befitting a multifactorial etiology.

Identifiants

pubmed: 32319733
doi: 10.1002/bdr2.1686
pmc: PMC7319423
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

688-698

Subventions

Organisme : Radboud university medical center
Pays : International

Informations de copyright

© 2020 The Authors. Birth Defects Research published by Wiley Periodicals, Inc.

Références

Health Promot Chronic Dis Prev Can. 2015 Jul;35(5):79-84
pubmed: 26186019
Am J Med Genet A. 2017 Jan;173(1):151-156
pubmed: 27717162
Epidemiology. 2015 Mar;26(2):169-76
pubmed: 25563433
Eur J Med Genet. 2018 Sep;61(9):513-517
pubmed: 29597096
Fertil Steril. 2009 Feb;91(2):305-15
pubmed: 19201275
Hum Reprod. 2005 Feb;20(2):328-38
pubmed: 15567881
Birth Defects Res A Clin Mol Teratol. 2012 Mar;94(3):134-40
pubmed: 22371321
Eur J Med Genet. 2011 Jan-Feb;54(1):34-41
pubmed: 20888933
Pediatr Surg Int. 2012 Jul;28(7):725-9
pubmed: 22422375
Pediatr Res. 2020 Feb;87(3):541-549
pubmed: 31499513
Teratology. 1982 Jun;25(3):385-94
pubmed: 7051398
Am J Med Genet A. 2005 Oct 15;138A(3):212-7
pubmed: 16152641
Am J Med Genet A. 2010 Mar;152A(3):781-3
pubmed: 20186790
Birth Defects Res A Clin Mol Teratol. 2008 Mar;82(3):169-72
pubmed: 18181216
Epidemiology. 1999 May;10(3):238-41
pubmed: 10230831
Birth Defects Res A Clin Mol Teratol. 2007 Sep;79(9):652-6
pubmed: 17668455
Birth Defects Res C Embryo Today. 2014 Dec;102(4):382-400
pubmed: 25546370
PLoS One. 2017 Jan 23;12(1):e0169869
pubmed: 28114395
PLoS One. 2014 Jan 09;9(1):e85313
pubmed: 24416387
N Engl J Med. 2012 May 10;366(19):1803-13
pubmed: 22559061
J Community Genet. 2018 Oct;9(4):407-410
pubmed: 29736796
Prenat Diagn. 2014 Mar;34(3):214-22
pubmed: 24222433
Am J Med Genet C Semin Med Genet. 2018 Dec;178(4):440-446
pubmed: 30580478
Congenit Anom (Kyoto). 2005 Sep;45(3):73-9
pubmed: 16131363
Am J Med Genet A. 2008 Dec 15;146A(24):3181-5
pubmed: 19006232
Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):152-8
pubmed: 20073076
Orphanet J Rare Dis. 2011 Aug 16;6:56
pubmed: 21846383
Birth Defects Res. 2019 Jan 15;111(2):62-69
pubmed: 30569656
Eur J Pediatr. 1985 Nov;144(4):331-7
pubmed: 4076249
Orphanet J Rare Dis. 2012 Sep 15;7:65
pubmed: 22978793
J Obstet Gynaecol Res. 2007 Aug;33(4):570-3
pubmed: 17688633
Birth Defects Res A Clin Mol Teratol. 2013 Aug;97(8):554-63
pubmed: 23913417
QJM. 2001 Aug;94(8):435-44
pubmed: 11493721
Pediatr Surg Int. 2000;16(8):541-5
pubmed: 11149389
Birth Defects Res. 2020 May 15;112(9):688-698
pubmed: 32319733
Birth Defects Res A Clin Mol Teratol. 2010 Oct;88(10):779-90
pubmed: 20706996
Congenit Anom (Kyoto). 2013 Jun;53(2):95-7
pubmed: 23751045
Hum Genet. 2010 Jun;127(6):731-3
pubmed: 20369369
BJOG. 2013 Aug;120(9):1066-74
pubmed: 23574029
Mol Syndromol. 2013 Feb;4(1-2):16-9
pubmed: 23653572
Hum Reprod. 2009 Feb;24(2):360-6
pubmed: 19010807

Auteurs

Romy van de Putte (R)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.

Iris A L M van Rooij (IALM)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.
Paediatric Surgery, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands.

Cynthia P Haanappel (CP)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.

Carlo L M Marcelis (CLM)

Department of Human Genetics, Nijmegen, The Netherlands.

Han G Brunner (HG)

Department of Human Genetics, Nijmegen, The Netherlands.
Department of Clinical Genetics and School for Oncology & Developmental Biology (GROW), Maastricht University Medical Center, Maastricht, The Netherlands.

Marie-Claude Addor (MC)

Department of Woman-Mother-Child, University Medical Center CHUV, Lausanne, Switzerland.

Clara Cavero-Carbonell (C)

Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.

Carlos M Dias (CM)

Epidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.

Elizabeth S Draper (ES)

Department of Health Sciences, University of Leicester, Leicester, UK.

Larraitz Etxebarriarteun (L)

Department of Health, Public Health Service, Basque Government Basque Country, Vitoria-Gasteiz, Spain.

Miriam Gatt (M)

Malta Congenital Anomalies Register, Directorate for Health Information and Research, Pietà, Malta.

Babak Khoshnood (B)

INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), DHU Risks in Pregnancy, Paris Descartes University, Paris, France.

Agnieszka Kinsner-Ovaskainen (A)

European Commission, Joint Research Centre (JRC), Ispra, Italy.

Kari Klungsoyr (K)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Division for Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway.

Jenny J Kurinczuk (JJ)

National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Anna Latos-Bielenska (A)

Department of Medical Genetics, University of Medical Sciences, Poznań, Poland.

Karen Luyt (K)

South West Congenital Anomaly Register (SWCAR), Bristol Medical School, University of Bristol, Bristol, UK.

Mary T O'Mahony (MT)

Department of Public Health, Health Service Executive - South, Cork, Ireland.

Nicola Miller (N)

National Congenital Anomaly and Rare Disease Registration Service, Public Health England, Newcastle upon Tyne, UK.

Carmel Mullaney (C)

Department of Public Health, Health Service Executive - South East, Kilkenny, Ireland.

Vera Nelen (V)

Provinciaal Instituut voor Hygiene (PIH), Antwerp, Belgium.

Amanda J Neville (AJ)

Registro IMER - IMER Registry (Emilia Romagna Registry of Birth Defects), Center for Clinical and Epidemiological Research, University of Ferrara, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.

Isabelle Perthus (I)

Auvergne registry of congenital anomalies (CEMC-Auvergne), Department of clinical genetics, Centre de Référence des Maladies Rares, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.

Anna Pierini (A)

Tuscany Registry of Congenital Defects (RTDC), Institute of Clinical Physiology - National Research Council / Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Hanitra Randrianaivo (H)

Register of congenital malformations of Reunion Island, CHU Réunion, St Pierre, France.

Judith Rankin (J)

Institute of Health & Society, Newcastle University, Newcastle, UK.

Anke Rissmann (A)

Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke University, Magdeburg, Germany.

Florence Rouget (F)

Brittany Registry of congenital anomalies, CHU Rennes, University Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Rennes, France.

Bruno Schaub (B)

French West Indies Registry, Registre des Malformations des Antilles (REMALAN), Maison de la Femme de la Mère et de l'Enfant, University Hospital of Martinique, Fort-de-France, France.

David Tucker (D)

CARIS, Public Health Wales, Singleton Hospital, Swansea, UK.

Diana Wellesley (D)

Wessex Clinical Genetics Department, Princess Anne Hospital, Southampton, UK.

Awi Wiesel (A)

Department of Pediatrics, Birth Registry Mainz Model, University Medical Center of Mainz, Mainz, Germany.

Natalya Zymak-Zakutnia (N)

OMNI-Net Ukraine Birth Defects Program and Khmelnytsky City Children's Hospital, Khmelnytsky, Ukraine.

Maria Loane (M)

Centre for Maternal, Fetal and lnfant Research, lnstitute of Nursing and Health Research, Ulster University, Belfast, UK.

Ingeborg Barisic (I)

Centre of Excellence for Reproductive and Regenerative Medicine, Children's Hospital Zagreb, Medical School University of Zagreb, Zagreb, Croatia.

Hermien E K de Walle (HEK)

Department of Genetics, EUROCAT Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jorieke E H Bergman (JEH)

Department of Genetics, EUROCAT Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Nel Roeleveld (N)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH